EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes and Treatment Strategy of Mirizzi’s Syndrome Treated With Surgery

Xiaojun Sui iD, Ming Li, Dapeng Zhang iD

The American Surgeon™ · 2025

DOI: 10.1177/00031348241267955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, 2025. Verfasst von Xiaojun Sui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Mirizzi Syndrome, Cholangiopancreatography, Endoscopic Retrograde. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is currently no standardized treatment for Mirizzi’s syndrome (MS). We aim to explore the surgical treatment strategy for MS by analyzing its clinical characteristics and treatment outcomes.

Methods

This retrospective study analyzed the clinical data of 130 patients with MS who underwent surgery at our hospital from April 2013 to April 2020.

Results

The study population comprised 130 patients with MS, with an approximately balanced sex ratio and a median age of 58.5 years. The preoperative diagnostic rate was 82.3%. The diagnostic accuracy of ERCP was 92.5%, higher than that of MRCP and ultrasound. All patients underwent surgical treatment, with 74 cases of laparoscopic surgery, 43 cases of laparotomy, and 13 cases of laparoscopic surgery converted to laparotomy. A total of 23 patients experienced short-term and long-term complications after surgery, with a complication rate of 17.7%. There was no statistical difference between laparoscopic surgery and open surgery in terms of intraoperative hemorrhage, operative time, and postoperative complication rate. However, the length of hospital stay was shorter in the laparoscopic surgery compared to the open surgery, which was statistically different from each other.

Conclusion

ERCP is the gold standard for the diagnosis of MS, especially for identifying the type of MS. ERCP plays an important role in both the preoperative and postoperative phases of MS. Our study demonstrated that laparoscopic surgery was a safe and feasible option for MS treatment, even requires less hospitalization than open surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mirizzi SyndromeCholangiopancreatography, Endoscopic RetrogradeHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAdultTreatment OutcomeLength of StayPostoperative ComplicationsLaparoscopyOperative TimeLaparotomyCholecystectomy, Laparoscopic

Stichwörter der Autor:innen

Mirizzi’s syndromecholecystocholedochal fistulacholedochoplastysubtotal cholecystectomy

Autor:innen und Institutionen

  • Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, China.
  • Tianjin NanKai Hospital, Tianjin, China.

ORCID-Profile: Xiaojun Sui, Dapeng Zhang

Zitieren

APA

Sui, X., Li, M., & Zhang, D. (2025). Clinical Outcomes and Treatment Strategy of Mirizzi’s Syndrome Treated With Surgery. The American Surgeon™. https://doi.org/10.1177/00031348241267955

Vancouver

Sui X, Li M, Zhang D. Clinical Outcomes and Treatment Strategy of Mirizzi’s Syndrome Treated With Surgery. The American Surgeon™. 2025. doi:10.1177/00031348241267955

BibTeX
@article{Sui2025,
  author = {Sui, Xiaojun and Li, Ming and Zhang, Dapeng},
  title = {Clinical Outcomes and Treatment Strategy of Mirizzi’s Syndrome Treated With Surgery},
  journal = {The American Surgeon™},
  year = {2025},
  doi = {10.1177/00031348241267955}
}
Kostenlos starten →